John Charles Thomas's most recent trade in Krystal Biotech Inc was a trade of 1,000 Common Stock done at an average price of $179.3 . Disclosure was reported to the exchange on June 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | John Charles Thomas | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.25 per share. | 25 Jun 2026 | 1,000 | 1,000 (0%) | 0% | 179.3 | 179,250 | Common Stock |
| Krystal Biotech Inc | John Charles Thomas | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 347.27 per share. | 25 Jun 2026 | 1,000 | 0 (0%) | 0% | 347.3 | 347,270 | Common Stock |
| Krystal Biotech Inc | John Charles Thomas | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 1,000 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | John Charles Thomas | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 302.03 per share. | 26 May 2026 | 642 | 0 (0%) | 0% | 302.0 | 193,903 | Common Stock |